| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |